134 related articles for article (PubMed ID: 36030587)
1. The role of transketolase in human cancer progression and therapy.
Hao S; Meng Q; Sun H; Li Y; Li Y; Gu L; Liu B; Zhang Y; Zhou H; Xu Z; Wang Y
Biomed Pharmacother; 2022 Oct; 154():113607. PubMed ID: 36030587
[TBL] [Abstract][Full Text] [Related]
2. The human transketolase-like proteins TKTL1 and TKTL2 are bona fide transketolases.
Deshpande GP; Patterton HG; Faadiel Essop M
BMC Struct Biol; 2019 Jan; 19(1):2. PubMed ID: 30646877
[TBL] [Abstract][Full Text] [Related]
3. A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.
Schneider S; Lüdtke S; Schröder-Tittmann K; Wechsler C; Meyer D; Tittmann K
PLoS One; 2012; 7(10):e48321. PubMed ID: 23118983
[TBL] [Abstract][Full Text] [Related]
4. TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinoma.
Shi Z; Tang Y; Li K; Fan Q
Tumour Biol; 2015 Nov; 36(11):8519-29. PubMed ID: 26032094
[TBL] [Abstract][Full Text] [Related]
5. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells.
Zhang S; Yang JH; Guo CK; Cai PC
Cancer Lett; 2007 Aug; 253(1):108-14. PubMed ID: 17321041
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma.
Zhang S; Yue JX; Yang JH; Cai PC; Kong WJ
Cancer Biol Ther; 2008 Apr; 7(4):517-22. PubMed ID: 18296915
[TBL] [Abstract][Full Text] [Related]
7. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
Langbein S; Zerilli M; Zur Hausen A; Staiger W; Rensch-Boschert K; Lukan N; Popa J; Ternullo MP; Steidler A; Weiss C; Grobholz R; Willeke F; Alken P; Stassi G; Schubert P; Coy JF
Br J Cancer; 2006 Feb; 94(4):578-85. PubMed ID: 16465194
[TBL] [Abstract][Full Text] [Related]
8. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo.
Yuan W; Wu S; Guo J; Chen Z; Ge J; Yang P; Hu B; Chen Z
Cancer Biol Ther; 2010 May; 9(9):710-6. PubMed ID: 20200485
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer.
Chen H; Yue JX; Yang SH; Ding H; Zhao RW; Zhang S
J Exp Clin Cancer Res; 2009 Mar; 28(1):43. PubMed ID: 19331662
[TBL] [Abstract][Full Text] [Related]
10. Transketolase-like protein 1 confers resistance to serum withdrawal in vitro.
Hartmannsberger D; Mack B; Eggert C; Denzel S; Stepp H; Betz CS; Gires O
Cancer Lett; 2011 Jan; 300(1):20-9. PubMed ID: 20884117
[TBL] [Abstract][Full Text] [Related]
11. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
12. Lack of transketolase-like (TKTL) 1 aggravates murine experimental colitis.
Bentz S; Pesch T; Wolfram L; de Vallière C; Leucht K; Fried M; Coy JF; Hausmann M; Rogler G
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G598-607. PubMed ID: 21233279
[TBL] [Abstract][Full Text] [Related]
13. [Effects of transketolase-like gene TKTL1 on occurrence and metastasis of human nasopharyngeal carcinoma].
Zhang S; Yang JH; Cai PC
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3131-4. PubMed ID: 19159596
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer.
Coy JF; Dressler D; Wilde J; Schubert P
Clin Lab; 2005; 51(5-6):257-73. PubMed ID: 15991799
[TBL] [Abstract][Full Text] [Related]
15. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells.
Xu X; Zur Hausen A; Coy JF; Löchelt M
Int J Cancer; 2009 Mar; 124(6):1330-7. PubMed ID: 19065656
[TBL] [Abstract][Full Text] [Related]
16. A review on research progress of transketolase.
Zhao J; Zhong CJ
Neurosci Bull; 2009 Apr; 25(2):94-9. PubMed ID: 19290028
[TBL] [Abstract][Full Text] [Related]
17. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
Qin Z; Xiang C; Zhong F; Liu Y; Dong Q; Li K; Shi W; Ding C; Qin L; He F
J Exp Clin Cancer Res; 2019 Apr; 38(1):154. PubMed ID: 30971297
[TBL] [Abstract][Full Text] [Related]
18. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
[TBL] [Abstract][Full Text] [Related]
19. Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.
Jia D; Liu C; Zhu Z; Cao Y; Wen W; Hong Z; Liu Y; Liu E; Chen L; Chen C; Gu Y; Jiao B; Chai Y; Wang HY; Fu J; Chen X
Clin Transl Med; 2022 Nov; 12(11):e1095. PubMed ID: 36314067
[TBL] [Abstract][Full Text] [Related]
20. Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation.
Li M; Zhao X; Yong H; Xu J; Qu P; Qiao S; Hou P; Li Z; Chu S; Zheng J; Bai J
Cell Death Dis; 2022 Feb; 13(2):99. PubMed ID: 35110545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
